Company Elanco Animal Health Incorporated Deutsche Boerse AG

Equities

5EA

US28414H1032

Pharmaceuticals

Real-time Estimate Tradegate 05:42:32 2024-05-31 am EDT 5-day change 1st Jan Change
16.22 EUR +1.72% Intraday chart for Elanco Animal Health Incorporated +5.07% +21.91%

Business Summary

Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Number of employees: 9,550

Sales per Business

USD in Million2022Weight2023Weight Delta
Pet Health
47.6 %
2,138 48.5 % 2,104 47.6 % -1.59%
Farm Animal - Cattle
21.5 %
944 21.4 % 949 21.5 % +0.53%
Farm Animal - Poultry
17.3 %
716 16.2 % 765 17.3 % +6.84%
Farm Animal - Swine
8.6 %
384 8.7 % 382 8.6 % -0.52%
Farm Animal - Aqua
4.0 %
175 4.0 % 175 4.0 % 0.00%
Contact Manufacturing
1.0 %
54 1.2 % 42 1.0 % -22.22%

Sales per region

USD in Million2022Weight2023Weight Delta
International
55.1 %
2,446 55.5 % 2,434 55.1 % -0.49%
United States
44.9 %
1,965 44.5 % 1,983 44.9 % +0.92%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 18-06-30
Director of Finance/CFO 52 18-12-13
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer 57 18-06-30
Investor Relations Contact - -
General Counsel 50 Oct. 31
Corporate Officer/Principal - 22-08-07
Corporate Officer/Principal 43 22-02-28
Corporate Officer/Principal - -
Comptroller/Controller/Auditor 54 18-09-23

Members of the board

Members of the board TitleAgeSince
Director/Board Member 61 20-12-13
Director/Board Member 63 19-05-07
Director/Board Member 67 19-03-10
Director/Board Member 66 18-08-31
Director/Board Member 67 19-03-10
Chairman 77 18-04-30
Director/Board Member 70 18-08-31
Director/Board Member 64 19-03-10
Chief Executive Officer 56 18-06-30
Director/Board Member 61 18-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 494,181,620 490,927,888 ( 99.34 %) 0 99.34 %

Shareholders

NameEquities%Valuation
Dodge & Cox
16.97 %
83,848,850 16.97 % 1 093 M €
PRIMECAP Management Co.
10.70 %
52,885,068 10.70 % 690 M €
Vanguard Fiduciary Trust Co.
9.969 %
49,258,240 9.969 % 642 M €
BlackRock Advisors LLC
5.027 %
24,837,802 5.027 % 324 M €
T. Rowe Price International Ltd.
4.481 %
22,139,018 4.481 % 289 M €
Black Creek Investment Management, Inc.
4.080 %
20,159,435 4.080 % 263 M €
Dimensional Fund Advisors LP
3.642 %
17,995,962 3.642 % 235 M €
Citadel Securities GP LLC
2.445 %
12,081,728 2.445 % 158 M €
Shapiro Capital Management LLC
2.205 %
10,893,298 2.205 % 142 M €
Ancora Alternatives LLC
2.154 %
10,641,194 2.154 % 139 M €

Company contact information

Elanco Animal Health, Inc.

2500 Innovation Way

46140, Greenfield

+877 352 6261

http://www.elanco.com
address Elanco Animal Health Incorporated(5EA)

Group companies

NameCategory and Sector
Food: Major Diversified
Elanco Austria GmbH
Finance/Rental/Leasing
Eli Lilly Trading SA
  1. Stock Market
  2. Equities
  3. ELAN Stock
  4. 5EA Stock
  5. Company Elanco Animal Health Incorporated